Eventide Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-145,000
| Closed | -$1.94M | – | 141 |
|
|
2017
Q3 | $1.94M | Hold |
145,000
| – | – | 0.11% | 106 |
|
|
2017
Q2 | $2.08M | Hold |
145,000
| – | – | 0.13% | 96 |
|
|
2017
Q1 | $3.07M | Hold |
145,000
| – | – | 0.2% | 85 |
|
|
2016
Q4 | $4.08M | Hold |
145,000
| – | – | 0.27% | 76 |
|
|
2016
Q3 | $3.88M | Hold |
145,000
| – | – | 0.24% | 75 |
|
|
2016
Q2 | $2.45M | Hold |
145,000
| – | – | 0.15% | 94 |
|
|
2016
Q1 | $3.08M | Buy |
+145,000
| New | +$3.08M | 0.17% | 89 |
|